Percutaneous Transhepatic Cholangiography Market Report 2025 (Global Edition)

Global Percutaneous Transhepatic Cholangiography Market Report 2025 Market Size Split by Type (PTC Plastic Pancreatic & Biliary Stenting Procedures, PTC Metal Pancreatic & Biliary Stenting Procedures)...

Percutaneous Transhepatic Cholangiography Market Report Description

We have various report editions of Percutaneous Transhepatic Cholangiography Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Percutaneous Transhepatic Cholangiography Market Insights Video

Competitive Landscape of the Percutaneous Transhepatic Cholangiography Market

The competitive landscape of the Percutaneous Transhepatic Cholangiography market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Percutaneous Transhepatic Cholangiography companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2022: CONMED's acquisition of In2Bones Global, Inc. significantly enhanced its capacity to address disorders and injuries in the upper and lower extremities. This strategic move broadened CONMED's product offerings to encompass implants, fracture fixation, arthroplasty, biologics, and associated hardware, culminating in the formation of CONMED Foot and Ankle. (Source: https://www.conmed.com/en/why-conmed/a-history-of-innovation ) April 2021: B. Braun Melsungen AG chose MuleSoft to streamline operations and enhance patient care by consolidating disparate data into a unified patient view. Leveraging MuleSoft's integration and API platform, B. Braun accelerated digital experience creation by 50%, securely unlocking and integrating critical data across systems while seamlessly connecting with its healthcare industry partners. (Source: https://www.salesforce.com/news/press-releases/2021/04/13/b-braun-melsungen-ag-accelerates-digital-healthcare-innovations-with-mulesoft/ )

Top Companies Market Share in Percutaneous Transhepatic Cholangiography Industry: (In no particular order of Rank)

• OLYMPUS CORPORATION
• CONMED Corporation
• TeleMed Systems
• Inc.
• Boston Scientific Corporation
• Merit Medical Systems
• KARL STORZ SE & Co. KG
• Braun Melsungen AG
• BD (Becton
• Dickinson
• and Company)
• FUJIFILM Corporation
• Medtronic (Ireland)
• HOBBS MEDICAL
• INC. (U.S.)
• SureCare (U.S.)
• Richard Wolf GmbH (Germany)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Percutaneous Transhepatic Cholangiography Market

Which Region Dominates the Percutaneous Transhepatic Cholangiography Market in 2024?

According to Cognitive Market Research, North America dominated the global Percutaneous Transhepatic Cholangiography market in 2024, accounting for around 40% of the global revenue. This was primarily due to the region's advanced healthcare infrastructure, the high adoption rate of advanced medical technologies, including minimally invasive procedures like Percutaneous Transhepatic Cholangiography (PTC), and substantial investments in healthcare research and development. Additionally, favorable reimbursement policies and the increasing prevalence of diseases requiring diagnostic imaging and interventional procedures further contributed to North America's prominent position in the market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Percutaneous Transhepatic Cholangiography (PTC) market due to several compelling reasons. Firstly, the region is experiencing rapid economic growth and increasing healthcare expenditures, which are driving investments in advanced medical technologies and infrastructure. There is a rising burden of liver diseases and disorders in Asia Pacific, attributed to factors such as changing lifestyles, increasing prevalence of hepatitis infections, and dietary habits. PTC is crucial for diagnosing and treating these conditions, thereby fueling the demand for such procedures in the region. Improvements in healthcare access and awareness about advanced diagnostic and interventional procedures among healthcare professionals and patients are enhancing the uptake of PTC in Asia Pacific countries.

 

The current report Scope analyzes Percutaneous Transhepatic Cholangiography Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Percutaneous Transhepatic Cholangiography Market Analysis

According to Cognitive Market Research, the global Percutaneous Transhepatic Cholangiography market size was estimated at USD XX Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Percutaneous Transhepatic Cholangiography market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The growth of the Percutaneous Transhepatic Cholangiography market in the United States is driven by the increasing prevalence of liver diseases, advancements in medical technology, and rising demand for precise diagnostic and therapeutic interventions.
• The Canada Percutaneous Transhepatic Cholangiography market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The growth of the Canadian percutaneous Transhepatic Cholangiography market is propelled by expanding healthcare infrastructure, technological advancements in medical imaging and interventional radiology, and a rising incidence of liver diseases requiring specialized diagnostic procedures.
• The Mexico Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD XX million in 2024.

Europe Percutaneous Transhepatic Cholangiography Market Analysis

According to Cognitive Market Research, the global Percutaneous Transhepatic Cholangiography market size was estimated at USD XX Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD XX million in 2024. It will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031.

• The United Kingdom Percutaneous Transhepatic Cholangiography market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. The United Kingdom's Percutaneous Transhepatic Cholangiography market is characterized by robust growth, driven by advancements in medical technology, increasing demand for minimally invasive procedures, and a rising prevalence of liver diseases necessitating advanced diagnostic and therapeutic interventions.
• The France Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the Germany Percutaneous Transhepatic Cholangiography market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period.
• The Italy Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 230.94 million in 2024.
• The Russia Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD XX million in 2024.
• The Spain Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD XX million in 2024
• The Luxembourg Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD XX million in 2024.
• The Portugal Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD XX million in 2024.
• The Greece Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD XX million in 2024.
• Rest of Europe's Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD XX million in 2024.

Asia Pacific Percutaneous Transhepatic Cholangiography Market Analysis

According to Cognitive Market Research, the global Percutaneous Transhepatic Cholangiography market size was estimated at USD XX Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Percutaneous Transhepatic Cholangiography market size was valued at USD 926.45 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast periodPercutaneous Transhepatic Cholangiography sales surge in China due to several contributing factors. The increasing incidence of liver diseases and disorders, exacerbated by factors such as hepatitis infections and dietary changes, drives demand for accurate diagnostic procedures like PTC.
• The Japan Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD XX million in 2024.
• The India Percutaneous Transhepatic Cholangiography market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period
• The South Korea Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD XX million in 2024.
• The Australia Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.
• The South East Asia Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of the Asia Pacific Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.

South America Percutaneous Transhepatic Cholangiography Market Analysis

According to Cognitive Market Research, the global Percutaneous Transhepatic Cholangiography market size was estimated at USD XX Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Percutaneous Transhepatic Cholangiography market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. percutaneous Transhepatic Cholangiography sales flourish in Brazil due to several factors. Firstly, there is a growing incidence of liver diseases in the country, attributed to factors such as viral hepatitis, alcohol consumption, and metabolic syndromes like non-alcoholic fatty liver disease (NAFLD). These conditions necessitate accurate diagnostic procedures like Percutaneous Transhepatic Cholangiography (PTC) to diagnose and manage liver-related disorders effectively.
• Argentina's Percutaneous Transhepatic Cholangiography market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina's technological advancements augment the demand to drive innovation in the logistics industry.
• Colombia's Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD XX million in 2024.
• Peru Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD XX million in 2024.
• Chile's Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Latin America Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD XX million in 2024.

Middle East Percutaneous Transhepatic Cholangiography Market Analysis

According to Cognitive Market Research, the global Percutaneous Transhepatic Cholangiography market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

• The GCC Countries Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 5.5% during the forecast period with a market size of USD XX million in 2024. Percutaneous Transhepatic Cholangiography sales flourish due to increasing healthcare infrastructure investments, advancements in medical technology, and a rising prevalence of liver diseases and related conditions in the region.
• The Egypt Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD XX million in 2024.
• The South Africa Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD XX million in 2024. Percutaneous Transhepatic Cholangiography sales flourish in South Africa due to increasing incidence of liver diseases, advancements in healthcare infrastructure, and rising demand for accurate diagnostic procedures.
• The Turkey Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD XX million in 2024.
• The Nigeria Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of the MEA Percutaneous Transhepatic Cholangiography market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD XX million in 2024.

Percutaneous Transhepatic Cholangiography Market Analysis

Percutaneous Transhepatic Cholangiography Market Type Segment Analysis

According to Cognitive Market Research, In the Percutaneous Transhepatic Cholangiography (PTC) market, the dominating segment is PTC Metal Pancreatic & Biliary Stenting Procedures. This segment holds a significant share due to the durability and effectiveness of metal stents in treating strictures and blockages in the pancreatic and biliary ducts. Metal stents are preferred for their ability to provide long-term patency and resistance to compression, making them suitable for managing complex cases of malignant and benign obstructions in these critical anatomical pathways.

The fastest-growing segment in the PTC market is PTC Plastic Pancreatic & Biliary Stenting Procedures. This growth is driven by advancements in biocompatible materials and design improvements that enhance flexibility and reduce the risk of complications associated with plastic stents. Plastic stents are increasingly favored for their ease of deployment, cost-effectiveness, and ability to be exchanged or removed without further invasive procedures, making them particularly suitable for temporary relief and managing benign strictures in the pancreatic and biliary systems.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Percutaneous Transhepatic Cholangiography Industry. Request a Free Sample PDF!

Percutaneous Transhepatic Cholangiography Market Application Segment Analysis

According to Cognitive Market Research, Jaundice remains the dominating segment in the Percutaneous Transhepatic Cholangiography (PTC) market. This is primarily due to its widespread occurrence as a symptom of various liver and bile duct disorders, including obstruction and inflammation. PTC plays a crucial role in diagnosing the underlying causes of jaundice by providing detailed imaging of the bile ducts and enabling therapeutic interventions such as stent placement or drainage procedures to alleviate symptoms and improve patient outcomes.

The fastest-growing segment in the PTC market is Stone Removal. With an increasing incidence of gallstones and bile duct stones globally, there is a rising demand for minimally invasive procedures like PTC for effective stone removal. PTC allows precise visualization and access to stones within the bile ducts, facilitating their extraction or fragmentation without the need for open surgery. This segment's growth is driven by advancements in imaging technology, which enhance the safety and efficacy of stone removal procedures, making them preferred options among patients and healthcare providers alike.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Percutaneous Transhepatic Cholangiography End-User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, Hospitals constitute the dominating segment in the Percutaneous Transhepatic Cholangiography (PTC) market, accounting for the largest share of procedures conducted globally. Hospitals are favored due to their comprehensive facilities, including advanced imaging equipment and skilled medical staff capable of performing complex PTC procedures. Moreover, hospitals often serve as referral centers for patients requiring specialized diagnostic and interventional radiology services, further consolidating their position as the primary end-user segment in the PTC market.

Specialty Clinics emerge as the fastest-growing segment in the Percutaneous Transhepatic Cholangiography market. These clinics are witnessing increased adoption of PTC procedures due to their focus on specialized care and outpatient services. Specialty clinics offer efficient access to diagnostic procedures like PTC, catering to the growing demand for minimally invasive interventions outside traditional hospital settings. Advancements in healthcare delivery models drive this trend, as patient preference for convenient care and the rising incidence of liver-related diseases require precise diagnostic imaging.

• Hospitals
• Specialty Clinics
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion